Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

12/22/2025
3 papers selected
93 analyzed

Analyzed 93 papers and selected 3 impactful papers.

Summary

Three impactful studies span neurocritical care, perioperative hemodynamics, and pain neurobiology. Early post-injury resting-state fMRI signatures robustly predicted 6‑month recovery after moderate–severe TBI. An AI-guided hemodynamic strategy reduced intraoperative hypotension in major head and neck surgery, and patient-derived sensory neurons revealed a specific hyperexcitable subclass as the source of spontaneous activity relevant to neuropathic pain.

Research Themes

  • Neuroprognostication after traumatic brain injury using resting-state functional connectivity
  • AI-assisted predictive hemodynamic monitoring to prevent intraoperative hypotension
  • Mechanistic origins of spontaneous activity in human pain iPSC-derived sensory neurons

Selected Articles

1. Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury.

80Level IICohort
Proceedings of the National Academy of Sciences of the United States of America · 2025PMID: 41428880

Across three prospective cohorts with early rs-fMRI after moderate–severe TBI, preservation of anticorrelated functional connectivity emerged as the strongest predictor of 6‑month outcomes, with high discrimination in training and independent testing cohorts. Findings suggest that early functional network integrity indexes recovery potential and may complement clinical prognostication to reduce self-fulfilling withdrawal biases.

Impact: Provides externally validated, imaging-based prognostic biomarkers shortly after TBI with direct relevance to life-sustaining therapy decisions. Bridges systems neuroscience and outcome prediction with high AUCs.

Clinical Implications: Incorporating early rs-fMRI network metrics into prognostic models may improve accuracy and support ethically sound decisions about continuation of life-sustaining therapy, care pathways, and rehabilitation intensity.

Key Findings

  • Early rs-fMRI in moderate–severe TBI identified preservation of anticorrelated networks as the strongest predictor of 6-month outcomes.
  • Predictive performance was high in the training cohort (mean cross-validated AUC 0.94) and remained good in an independent testing cohort (AUC 0.78).
  • Functional connectivity biomarkers derived shortly after injury enabled individual-level prognostication beyond conventional clinical variables.

Methodological Strengths

  • Prospective, multi-cohort design with independent external validation.
  • Objective neuroimaging biomarkers assessed early after injury with strong discrimination metrics.

Limitations

  • Abstract truncation limits full detail; potential confounders (sedation, scan timing) are not delineated.
  • Moderate sample size may limit subgroup generalizability.

Future Directions: Standardize acquisition/analysis pipelines, validate in larger multi-center cohorts, and test integration with clinical/serological markers to guide targeted neurorehabilitation.

Some patients with moderate to severe traumatic brain injury (TBI) make a full recovery, while others remain severely disabled. Accurate prognostication is important, because withdrawal of life-sustaining therapy based on perceived poor prognosis is the leading cause of death after TBI. Synchronized activity between brain regions, measurable with resting-state functional MRI (rs-fMRI), may underlie neurological recovery. However, which functional connections are critical for recovery, and whether functional connectivity measured shortly after brain injury predicts long-term recovery, is unknown. Here, we analyzed data from three prospective cohorts of patients with moderate or severe TBI (N = 116 patients; 134 controls) who underwent rs-fMRI shortly after injury. The strongest predictor of 6-mo functional outcomes in the Training Cohort (mean cross validation AUC 0.94) and independent Testing Cohort (AUC 0.78;

2. Spontaneous activity in pain patient stem cell-derived sensory neurons arises from one functional subclass.

74.5Level IVCase-control
Pain · 2025PMID: 41428412

Patient-derived iPSC sensory neurons segregated into four functional classes, but only the tonically firing subclass exhibited spontaneous hyperexcitability, mirroring CMi nociceptor activity seen in patient microneurography. Spontaneous activity correlated with reduced action potential threshold and increased spontaneous depolarizing membrane fluctuations, pinpointing a mechanistic origin for pathological C-fiber activity.

Impact: Provides a precise cellular mechanism and target (tonically firing nociceptors) for spontaneous activity driving neuropathic pain, aligning human in vitro and in vivo readouts.

Clinical Implications: Therapeutic development can prioritize modulators that normalize excitability in the tonically firing nociceptor subclass; patient-specific iSN platforms may enable precision pharmacology screens.

Key Findings

  • Four functional subclasses were identified in human iPSC-derived sensory neurons, with spontaneous activity confined to a tonically firing subclass.
  • Spontaneous activity correlated with reduced action potential threshold and increased spontaneous depolarizing membrane fluctuations.
  • In vitro neuronal behavior recapitulated patient microneurography findings implicating CMi (“sleeping”) nociceptors in neuropathic pain.

Methodological Strengths

  • Use of patient-derived iPSC sensory neurons enabling human, cell-type–specific mechanistic interrogation.
  • Convergence of electrophysiology with patient microneurography for translational alignment.

Limitations

  • Limited number of patient donors constrains generalizability across neuropathic pain etiologies.
  • In vitro model lacks full in vivo context (immune and microenvironmental influences).

Future Directions: Expand donor cohorts across pain phenotypes, dissect ion channel and membrane noise contributors, and perform targeted pharmacology to reverse tonic-subclass hyperexcitability.

Spontaneous activity of peripheral sensory nerve fibers is one of the main drivers of neuropathic pain. It can be assessed in microneurography recordings of patients' C fibers and in patch-clamp recordings of dissociated dorsal root ganglia from humans and rodents. In microneurography of human C fibers, a distinct subgroup of neurons, the so-called mechano-insensitive (CMi) or sleeping nociceptors, shows spontaneous activity during neuropathic pain. It was shown before that sensory neurons from patient-derived induced pluripotent stem cells (iSNs) can be used to model this increased spontaneous activity in vitro, suggesting that a disease relevant cell type is generated with this approach. The origin of the spontaneous activity in human C fibers is not fully understood. Derived sensory neurons offer the unique possibility to study patient-derived, single-cell function, allowing for identification of potential mechanisms underlying spontaneous C-fiber activity. Here, we identify 4 distinct functional subtypes of iSNs from healthy donors and a patient suffering from the neuropathic pain syndrome inherited erythromelalgia using patch-clamp recordings. Similar to microneurography recordings from the same patient, spontaneous activity is restricted to 1 functional subgroup that shows tonic firing behavior and seems to be especially prone to develop neuronal hyperexcitability. We demonstrate that spontaneous activity correlates with a reduced voltage threshold of action potential generation and increased spontaneous depolarizing fluctuations of the membrane potential. Our findings reveal that only the tonically firing functional subclass of iSNs shows spontaneous activity and suggest that these neurons may be related to the pathologically active CMi fibers identified during microneurography recordings in patients with pain.

3. Artificial intelligence-based predictive hemodynamic monitoring in conjunction with goal-directed therapy reduces duration, frequency, and severity of intraoperative hypotension in major maxillofacial and otolaryngological surgery-a prospective randomized controlled pilot trial.

64Level IIRCT
Journal of anesthesia, analgesia and critical care · 2025PMID: 41423680

In a three-arm randomized pilot trial (n=75), HPI-guided goal-directed therapy significantly reduced the number and total duration of intraoperative hypotension episodes compared with standard care in major head and neck surgery, whereas classical GDT alone did not. Secondary outcomes, including complications, did not differ, underscoring the need for larger trials.

Impact: Demonstrates the practical value of AI-driven predictive monitoring to preempt hypotension—an established mediator of perioperative organ injury—in a randomized setting.

Clinical Implications: HPI-guided protocols can be considered to reduce hypotension exposure during long, blood loss–prone head and neck procedures, while larger studies should verify downstream organ-protective benefits.

Key Findings

  • HPI-guided management halved median IOH episodes (3.0 vs 7.0) and markedly reduced total IOH duration (7 vs 46 minutes) versus control.
  • Classical GDT without HPI did not reduce hypotension compared with control.
  • Secondary outcomes (eg, TWA MAP<65 mmHg, postoperative complications) were similar across groups in this pilot.

Methodological Strengths

  • Randomized controlled, three-arm design with blinded monitoring in control arm.
  • Objective, clinically relevant primary endpoints (frequency and duration of IOH) with clear MAP threshold.

Limitations

  • Single-center pilot with limited sample size; not powered for clinical outcomes.
  • Generalizability to other surgical populations and anesthesia techniques requires confirmation.

Future Directions: Multicenter adequately powered trials assessing renal, cardiac, and neurologic outcomes; cost-effectiveness and workflow integration studies.

BACKGROUND: Intraoperative hypotension (IOH) during non-cardiac surgery is associated with increased risk of postoperative complications, including acute kidney injury, myocardial injury, stroke, and mortality. Artificial intelligence-based predictive hemodynamic monitoring using the Hypotension Prediction Index (HPI), combined with goal-directed therapy (GDT), has been proposed to reduce IOH. However, its effectiveness in major maxillofacial and otolaryngologic surgery remains unclear. The purpose of the study was to assess whether HPI-guided management or classical GDT reduces IOH compared to standard care in patients undergoing major maxillofacial and otolaryngologic surgery. METHODS: In this randomized controlled pilot trial at a university hospital, 75 patients were allocated to one of three groups: control (n = 25), HPI-guided GDT (n = 25), or classical GDT without HPI (n = 25). In the control group, the advanced hemodynamic monitoring was blinded to the anesthesiologist. IOH was defined as mean arterial pressure (MAP) < 65 mmHg for > 1 min. Primary endpoints were the number and total duration of IOH episodes. Secondary endpoints included the time-weighted average MAP < 65 mmHg (TWA65) and postoperative complications. RESULTS: Seventy-four patients were analyzed. The HPI group showed significantly fewer IOH episodes (median 3.0 vs. 7.0; p = 0.02) and shorter IOH duration (7.0 min vs. 46.0 min; p < 0.01) compared to control. No significant difference was observed between the classical GDT and control groups. Secondary outcomes were comparable across all groups. CONCLUSIONS: HPI-guided hemodynamic management significantly reduces the frequency and duration of IOH in major head and neck surgery. Larger studies are needed to evaluate effects on clinical outcomes. TRIAL REGISTRATION: The trial was registered on clinicaltrials.gov (NCT04151264) on 14th October 2019.